Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
22.4K
-
Total reported value, excl. options
-
$55K
-
Value change
-
$0
-
Price
-
$2.46
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q3 2019
1 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q3 2019.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.4K shares
of 71.9M outstanding shares and own 0.03% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.84M shares), RENAISSANCE TECHNOLOGIES LLC (2.38M shares), Neumann Advisory Hong Kong Ltd (316K shares), STATE STREET CORP (161K shares), Yorktown Management & Research Co Inc (74.9K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (68.7K shares), Skandinaviska Enskilda Banken AB (publ) (40K shares), GEODE CAPITAL MANAGEMENT, LLC (27.7K shares), NORTHERN TRUST CORP (22.4K shares), and Eqis Capital Management, Inc. (20.7K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.